BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20733275)

  • 1. Clinical significance of heme oxygenase-1 expression in non-muscle-invasive bladder cancer.
    Miyake M; Fujimoto K; Anai S; Ohnishi S; Nakai Y; Inoue T; Matsumura Y; Tomioka A; Ikeda T; Tanaka N; Hirao Y
    Urol Int; 2010; 85(3):355-63. PubMed ID: 20733275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of heme oxygenase-1, S100 calcium-binding protein A4, and syndecan-1 expression in primary non-muscle-invasive bladder cancer.
    Kim JH; Park J
    Hum Pathol; 2014 Sep; 45(9):1830-8. PubMed ID: 24957789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of p53 and Ki-67 expression in intermediate-risk patients with nonmuscle-invasive bladder cancer receiving adjuvant intravesical mitomycin C therapy.
    Seo HK; Cho KS; Chung J; Joung JY; Park WS; Chung MK; Lee KH
    Urology; 2010 Aug; 76(2):512.e1-7. PubMed ID: 20579709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
    Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
    J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
    Ding W; Gou Y; Sun C; Xia G; Wang H; Chen Z; Tan J; Xu K; Qiang D
    Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme oxygenase-1 expression is associated with tumor aggressiveness and outcomes in patients with bladder cancer: a correlation with smoking intensity.
    Miyata Y; Kanda S; Mitsunari K; Asai A; Sakai H
    Transl Res; 2014 Dec; 164(6):468-76. PubMed ID: 25063314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
    Miyake M; Fujimoto K; Anai S; Ohnishi S; Kuwada M; Nakai Y; Inoue T; Matsumura Y; Tomioka A; Ikeda T; Tanaka N; Hirao Y
    Oncol Rep; 2011 Mar; 25(3):653-60. PubMed ID: 21206978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?
    Park J; Song C; Shin E; Hong JH; Kim CS; Ahn H
    Urol Oncol; 2013 Aug; 31(6):849-56. PubMed ID: 21782482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twist confers chemoresistance to anthracyclines in bladder cancer through upregulating P-glycoprotein.
    Chen Y; Li L; Zeng J; Wu K; Zhou J; Guo P; Zhang D; Xue Y; Liang L; Wang X; Chang LS; He D
    Chemotherapy; 2012; 58(4):264-72. PubMed ID: 22986993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
    Kim K; Cho YM; Park BH; Lee JL; Ro JY; Go H; Shim JW
    Int J Clin Exp Pathol; 2015; 8(1):743-50. PubMed ID: 25755769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
    Gandour-Edwards R; Lara PN; Folkins AK; LaSalle JM; Beckett L; Li Y; Meyers FJ; DeVere-White R
    Cancer; 2002 Sep; 95(5):1009-15. PubMed ID: 12209684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines.
    Miyake M; Ishii M; Kawashima K; Kodama T; Sugano K; Fujimoto K; Hirao Y
    Photochem Photobiol; 2009; 85(4):1020-7. PubMed ID: 19320847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
    Liu B; Miyake H; Nishikawa M; Fujisawa M
    Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of doxorubicin in human bladder tumors.
    Gan Y; Wientjes MG; Badalament RA; Au JL
    Clin Cancer Res; 1996 Aug; 2(8):1275-83. PubMed ID: 9816297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
    Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
    Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment.
    Berberat PO; Dambrauskas Z; Gulbinas A; Giese T; Giese N; Künzli B; Autschbach F; Meuer S; Büchler MW; Friess H
    Clin Cancer Res; 2005 May; 11(10):3790-8. PubMed ID: 15897578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
    Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
    Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer.
    Boschetto P; Zeni E; Mazzetti L; Miotto D; Lo Cascio N; Maestrelli P; Marian E; Querzoli P; Pedriali M; Murer B; De Rosa E; Fabbri LM; Mapp CE
    Lung Cancer; 2008 Feb; 59(2):192-7. PubMed ID: 17900753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.